340B News
- Strategies to Ensure 340B Savings
-
July 1, 2010
PHARMACY PURCHASING & PRODUCTS MAGAZINE – In theory, the 340B Drug Pricing Program is fairly straightforward: Covered entities are eligible to purchase substantially discounted pharmaceuticals for qualified patients, provided they adhere to established guidelines and statutory requirements. Read More
- Maximize 340B Purchasing Power
-
March 19, 2010
PHARMACY PURCHASING & PRODUCTS – Participation in the 340B Drug Pricing Program presents many cost savings opportunities for covered entities. The obvious advantage lies in the manufacturers’ discounts—on average 51% less than the average wholesale price (AWP). However, with a deeper understanding of how the 340B program operates, participants can leverage even greater discounts and cost savings via their 340B status. Read More

Subscribe to Talyst 340B News RSS Feed
